Description
Indications
Herpes simplex nosode is traditionally associated with chronically recurrent herpes infections of whatever causation and location — including cold sores and recurrent herpes labialis. It is also linked with herpetiform skin diseases and other types of herpes, and with infectious diseases caused by medicaments which may present alongside a herpes labialis. It is used where a herpes-related agent can be recognised in the clinical picture.
About the remedy
Herpes Simplex nosode Injeel is a single-remedy homeopathic preparation from Heel's antihomotoxic Injeel range. It is a nosode — a preparation made from a potentised, inactivated disease-related source (dead herpes simplex virus material) — used according to the isopathic principle, whereby a highly diluted, potentised form of the disease agent is given to address disorders connected with that same agent.
Composition
Each 1.1 ml ampoule contains: Herpes simplex nosode D12, D30, D200 — 0.367 ml each.
Suggested use
Supplied as ampoules of 1.1 ml. The solution may be taken orally or used by injection (i.m., s.c., i.d. or i.v.). A general guideline is the contents of one ampoule 1–3 times weekly; in acute situations it may be used more frequently, or as directed.
Description
Indications
Herpes simplex nosode is traditionally associated with chronically recurrent herpes infections of whatever causation and location — including cold sores and recurrent herpes labialis. It is also linked with herpetiform skin diseases and other types of herpes, and with infectious diseases caused by medicaments which may present alongside a herpes labialis. It is used where a herpes-related agent can be recognised in the clinical picture.
About the remedy
Herpes Simplex nosode Injeel is a single-remedy homeopathic preparation from Heel's antihomotoxic Injeel range. It is a nosode — a preparation made from a potentised, inactivated disease-related source (dead herpes simplex virus material) — used according to the isopathic principle, whereby a highly diluted, potentised form of the disease agent is given to address disorders connected with that same agent.
Composition
Each 1.1 ml ampoule contains: Herpes simplex nosode D12, D30, D200 — 0.367 ml each.
Suggested use
Supplied as ampoules of 1.1 ml. The solution may be taken orally or used by injection (i.m., s.c., i.d. or i.v.). A general guideline is the contents of one ampoule 1–3 times weekly; in acute situations it may be used more frequently, or as directed.